research Androgenetic alopecia: Update on etiology
AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.
Search
forProducts matching "early androgenic alopecia"
Tracking 3 products like 151 Tugain 5 Solution (Minoxidil 5%), 178 Hair4u 10% and 179 Tugain 5% 60ml from by companies like Inhouse Pharmacy and ReliableRxpharmacy. View all 3 products »
Sort by
Research
990-1000 / 1000+ results 
research Trichobiolight: A new, effective protocol in the treatment of androgenetic alopecia and telogen effluvium
Trichobiolight effectively treats hair loss with 82.5% success.
research The potential of androgenic alopecia management from plant derivatives
Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.
research PLATELET RICH PLASMA IN ANDROGENIC ALOPECIA IN MALE AND FEMALE PATIENTS- A MYTH, A PROSPECTIVE STUDY
Platelet Rich Plasma (PRP) injections can effectively reduce hair loss and improve hair growth in both men and women suffering from androgenic alopecia.
research Association of Androgenic Alopecia with Metabolic Syndrome
People with male pattern baldness are more likely to have metabolic syndrome.
research Androgenic Alopecia: Cross-Talk Between Cell Signal Transduction Pathways
Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.
research Adverse Effects of 5-Alpha Reductase Inhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern?
5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.
research Genetic analysis of 5 α reductase type 2 enzyme in relation to oxidative stress in cases of androgenetic alopecia in a sample of egyptian population
5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.
research Interventions for androgenic alopecia in women
Review finds no permanent solution for female hair loss.
research Interventions for androgenic alopecia in women
Review determines effective, safe treatments for female hair loss.